BiotechTube
Home/Flavocure Biotech/Henry C. Lowe, PhD
HC

Henry C. Lowe, PhD

Executive Chairman, Founder

Flavocure Biotech

Therapeutic Areas

OncologyNeurology

Flavocure Biotech Pipeline

DrugIndicationPhase
CaflanonePancreatic Cancer / PancreatoblastomaIND ready
CSF1-R ProgramGlioblastoma (GBM) / MyelomaPre-Clinical
Caflanone / HLNT-06CNS DiseasesPre-Clinical
NCDx™CNS Diseases (Diagnostic)Pre-Clinical
NanoCaflanone™ PlatformOncology (e.g., brain metastases)Pre-Clinical
NCThera™CNS & OncologyPre-Clinical

Leadership Team at Flavocure Biotech

NJ
Ngeh J. Toyang, PhD
CEO, Co-Founder & Interim CSO
DB
David Brooks, MD, PhD
Interim Chief Medical Officer
TL
Thomas Lang, PhD
VP, Quality and Regulatory Affairs
View full Flavocure Biotech profile